
-
Tottenham sign Japan defender Takai
-
Cambodian garment workers fret Trump's new tariff threat
-
Israel-Hamas ceasefire negotiations resume as Trump pushes for deal
-
Trial of Slovak gunman who shot PM begins
-
Wallabies' Lolesio faces long rehab after surgery
-
Lions not invincible says former All Blacks coach Foster
-
Markets rise as Trump sends tariff letters, delays deadline
-
Australia-born Lion Hansen faces 'pinch-me' moment against old team
-
Mitre by mitre: N. Macedonian nuns craft priceless holy headwear
-
S.Leone islanders despair as rising ocean threatens survival
-
Bulgaria to get final green light to adopt euro in 2026
-
Major garment producer Bangladesh seeks deal after 35% US tariff
-
France's Macron kicks off pomp-filled UK state visit
-
Mbappe and PSG set for Club World Cup reunion as Real Madrid eye final
-
US to send 'more weapons' to Ukraine: Trump
-
Most markets rise as Trump sends tariff letters, delays deadline
-
Slovak gunman who shot PM to go on trial
-
As heatwaves intensify, Morocco ups effort to warn residents
-
All Blacks captain Scott Barrett out for rest of France series
-
AI video becomes more convincing, rattling creative industry
-
Trump says new tariff deadline 'not 100 percent firm'
-
Trump hosts Netanyahu in push for Gaza deal
-
Alpha males are rare among our fellow primates: scientists
-
At least 10 dead in Kenya during protests after heavy police deployment
-
American Critical Minerals Highlights Recent Positive Developments in Close Proximity to its Green River Potash and Lithium Project, Reinforcing the Potential of the Project
-
MMJ International Redefines Medical Cannabis with First Plant-Based Drug for a Rare Neurological Disease
-
Star Copper Confirms Two Prospective Copper Zones and Identifies Large Magnetic Anomaly as Daily Drilling Continues
-
Nano One Positioned for Rising LFP Demand, Aligned with Energy Strategies & Supporting Critical Mineral Localization Efforts Worldwide
-
Karbon-X Becomes Official Name Sponsor of BK Dukes Basketball Team
-
Angle PLC Announces Parsortix Enables Study Of Cancer Progression
-
Empire Metals Limited Announces Completion of MRE Drilling Campaign
-
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
-
Alcaraz, Sabalenka headline action in Wimbledon quarter-finals
-
Trump unveils first wave of steeper US tariffs, extends deadline
-
Knicks hire two-time NBA Coach of the Year Brown to guide club
-
Medical groups sue US health secretary over Covid-19 vaccine change
-
Now 48, man becomes 140th 'stolen grandchild' tracked in Argentina
-
Sinner wins Wimbledon reprieve after Dimitrov injury heartbreak, Djokovic survives
-
Trump unveils first wave of steeper US tariffs in push for deals
-
Swiss MLS goalie Frei resting at home after on-field collision
-
Relentless Spain reach Euro 2025 quarters after thumping Belgium
-
US stocks retreat from records on Trump tariff deluge
-
MLB Nationals name Cairo interim manager after shake-up
-
Sinner into Wimbledon quarter-finals after injury heartbreak for Dimitrov
-
Pacers guard Haliburton will miss entire '25-26 NBA season
-
Texas floods: How geography, climate and policy failures collided
-
Sinner into Wimbledon quarters after injured Dimitrov retires
-
UN General Assembly condemns 'systematic oppression' of women in Afghanistan
-
Epstein died by suicide, did not have 'client list': govt memo
-
Trump, Brazil's Lula clash over politically charged coup trial

US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
O.Karlsson--AMWN